Contineum Therapeutics, Inc. CTNM
- PIPE-791 — Idiopathic Pulmonary Fibrosis Phase 2
- PIPE-791 — Chronic Pain Phase 1
LPAR1 (1 companies · 2 programs)
Companies with an active program directed at LPAR1.
Companies with an active program directed at LPAR1.